RxDoctor Payments Data

Eric Haeger, MD

Sleep Medicine · Brewster, WANPI 1366404592

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $921 of the $1,296 with a category attached, or 71.1%. 6 manufacturers reported payments, led by Jazz Pharmaceuticals Inc. at 39.1% of the total. 2025 is the largest year on record at $406, more than ten times the $38 reported in 2019.

$1,296in general payments, 2019–2025

Across 46 payments — averaging $28.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Jazz Pharmaceuticals Inc.$507
  • Harmony Biosciences LLC$373
  • Vanda Pharmaceuticals Inc.$159
  • Axsome Therapeutics, Inc.$129
  • Resmed Corp$95
  • Avadel CNS Pharmaceuticals, LLC$34

What the payments were for

  • Food & beverage$92171%
  • Education$37529%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,296 in reported general payments places this provider in the 60th percentile of 67 sleep medicine providers in Washington.

See all sleep medicine providers in Washington

Medicare billing

Part B allowed, 2024
$188,323
Medicare patients
641
Services billed
1,306

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban57$18,334
XareltoRivaroxaban27$10,905
MyrbetriqMirabegron33$7,369
ButransBuprenorphine13$6,694
Spiriva HandihalerTiotropium Bromide11$6,385
ZyprexaOlanzapine19$6,360
AbrysvoRsv Vacc, Pref A And Pref B/Pf18$5,979
Fentanyl40$3,389
Potassium Chloride90$2,610
Gabapentin70$1,857
Lidocaine Hcl77$1,649
Scopolamine14$1,373
Memantine Hcl18$1,289
Atorvastatin Calcium82$1,258
Furosemide94$1,220

Paid to pharmacies, not to this prescriber.

Other sleep medicine in Brewster

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →